ABCL vs. SGMO

Last updated Aug 1, 2026

ABCL (AbCellera Biologics Inc.) and SGMO (Sangamo Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Their 0.34 correlation means their historical movements had little consistent relationship.

Performance

ABCL vs. SGMO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AbCellera Biologics Inc. (ABCL) and Sangamo Therapeutics, Inc. (SGMO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ABCL

• 1D: 0.35%
• 1M: -29.59%
• 6M: 57.73%
• YTD: 66.96%
• 1Y: 34.67%
• 3Y*: -7.74%
• 5Y*: -17.75%
• 10Y*: —
• ALL TIME*: -34.32%

SGMO

• 1D: —
• 1M: —
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
ABCL AbCellera Biologics Inc.	$27.22M	$36.48M	$44.45M

ABCL vs. SGMO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
ABCL AbCellera Biologics Inc.	66.96%	16.72%	-48.69%	-43.63%	-29.16%	-64.46%	-34.03%
SGMO Sangamo Therapeutics, Inc.	-82.38%	-58.82%	87.74%	-82.70%	-58.13%	-51.94%	-0.29%

Correlation

The correlation between ABCL and SGMO is 0.25, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.25
Correlation (3Y) Balances recent behavior with more history.	0.30
Correlation (5Y) Shows whether the relationship held over a longer period.	0.36
Correlation (All Time) Calculated using the full available price history since Dec 11, 2020	0.34

The correlation between ABCL and SGMO shifts across timeframes, from 0.25 (1 year) to 0.36 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ABCL : $1.74B SGMO : $30.66M
EPS ABCL : -$0.48 SGMO : -$0.36
PS Ratio ABCL : 21.64 SGMO : 0.74
Total Revenue (TTM) ABCL : $79.21M SGMO : $34.56M
Gross Profit (TTM) ABCL : $70.89M SGMO : $25.51M
EBITDA (TTM) ABCL : -$166.07M SGMO : -$106.29M

Return for Risk

ABCL vs. SGMO — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ABCL

ABCL Risk / Return Rank: 58
ABCL Sharpe Ratio Rank: 58
ABCL Sortino Ratio Rank: 61
ABCL Omega Ratio Rank: 58
ABCL Calmar Ratio Rank: 57
ABCL Martin Ratio Rank: 56

SGMO

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ABCL vs. SGMO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AbCellera Biologics Inc. (ABCL) and Sangamo Therapeutics, Inc. (SGMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ABCL	SGMO	Difference
Sharpe ratio: Return per unit of total volatility	0.36	—	—
Sortino ratio: Return per unit of downside risk	1.08	—	—
Omega ratio: Gain probability vs. loss probability	1.12	—	—
Calmar ratio: Return relative to maximum drawdown	0.51	—	—
Martin ratio: Return relative to average drawdown	0.91	—	—

Drawdowns

Drawdown Indicators

	ABCL	SGMO	Difference
Max Drawdown Largest peak-to-trough decline	-96.84%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-54.94%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-68.05%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-90.96%	—	—
Current Drawdown Current decline from peak	-90.64%	—	—
Average Drawdown Average peak-to-trough decline	-84.26%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	30.52%	—	—

Volatility

Volatility by Period

	ABCL	SGMO	Difference
Volatility (1M) Calculated over the trailing 1-month period	22.72%	—	—
Volatility (6M) Calculated over the trailing 6-month period	58.57%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	77.27%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	67.67%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	70.72%	—	—

Dividends

ABCL vs. SGMO - Dividend Comparison

Neither ABCL nor SGMO has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ABCL and SGMO in my portfolio?

ABCL and SGMO have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.